2015 Clinical Trials Consumption Extraction 
FloridaMarijuana.net
AUGUST 15, 2018
Exposure to toxins may damage nerves and cause peripheral neuropathy: medication toxicity, environmental or industrial toxins and heavy alcohol consumption. Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. Small vessel disease. Infections.
The Cannigma
MAY 13, 2022
There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. A 2015 study of 279 Israeli cancer patients found that 70% of participants reported a reduction in pain and improvement in quality of life, 60% reported an increase in appetite and 50% reported a reduction in nausea.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Canna Care Docs
DECEMBER 16, 2020
As with any prescription, marijuana does not offer a one-size-fits-all solution: there are a range of products available with different strains, chemical structures, dosages, and forms of consumption that all can impact the effectiveness for each user. The staff at your dispensary can help you find the product that’s right for you.
Greencamp
AUGUST 16, 2018
Even though these effects were observed on mice, all mammals have neurological and cellular similarities, and the team in charge of this study concluded that: “With respect to the treatment of ALS, from both a disease modifying and symptom management viewpoint, clinical trials with cannabis are the next logical step.
Cannabis Law Report
NOVEMBER 24, 2021
Researchers in Israel, Sweden, Estonia, and the USA have investigated media discourses about medicinal cannabis (Sznitman and Lewis 2015 ; Lewis et al. 2015 ; Kaiser 2011 ; Mortensen et al. No negative articles appear in these medical publications until 2015. A number of new frames also emerged during the coding process (e.g.
Cannabis Law Report
JULY 12, 2019
Recent studies on the effectiveness of cannabidiol in the rare seizure disorders Dravet Syndrome and Lennox-Gastaut syndrome have prompted a biopharmaceutical company to perform clinical trials of its own to bring a cannabidiol based drug to the American market through the process of FDA approval.
Cannabis Law Report
OCTOBER 29, 2019
Safety is imperative for any reputable brand of hemp extract, and we are confident that the dosing we recommend is both safe and effective,” said Dr. Wakshlag, Chief Medical Officer at ElleVet Sciences. The clinical trial results confirmed more than 80% of dogs showed significant or dramatic improvement. Wakshlag, DVM, Ph.D.,
Expert insights. Personalized for you.
150 
Let's personalize your content